Abstract
Castleman's disease is a rare cause of lymphoid hyperplasia that may result in localized symptoms or an aggressive, multisystem disorder that can mimic other diseases like lymphoma or tuberculosis. We describe a case of a 55-year-old Ghanaian male who was successfully diagnosed and managed for multicentric Castleman's disease with combination chemotherapy.
Keywords:
Plasma cell; Rituximab; chemotherapy; lymphadenopathy; multicentric Castleman's disease.
MeSH terms
-
Antibodies, Monoclonal, Murine-Derived / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biopsy
-
Castleman Disease / diagnosis
-
Castleman Disease / drug therapy*
-
Castleman Disease / pathology*
-
Cyclophosphamide / administration & dosage
-
Humans
-
Immunohistochemistry
-
Male
-
Middle Aged
-
Prednisolone / administration & dosage
-
Rituximab
-
Vincristine / administration & dosage
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Rituximab
-
Vincristine
-
Cyclophosphamide
-
Prednisolone